Home > Products > API > Ciprofloxacin HCl
Ciprofloxacin HCl
  • Ciprofloxacin HClCiprofloxacin HCl

Ciprofloxacin HCl

Product Name: Ciprofloxacin HCl
Formulae hypotheticae: C17H18FN3O3.HCl
M. Pondus: 367.8
CAS Subcriptio Number: 93107-08-5

Model:CAS NO:93107-08-5

Mitte Inquisitionem

depictio producti

Ciprofloxacin HCl

Product nomen:Ciprofloxacin HCl 93107-08-5
CAS No:93107-08-5
Specification: in domo

Nomen Ciprofloxacin HCl
Synonyma 3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride;1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin- 1-yl)-1,4-dihydroquinolino-3-carboxylicacidhydrochloride;3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazChemic albookinyl)-, hydrochloride(1:1); CIPROFLOXACINHYDROCHLORIDE;BY-o-9867; inolinecarboxylicacidmonohydrochloride;3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, monohydrochloride
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C17H18FN3O3.HCl
M. Pondus 367.8
CAS Subcriptio Number 93107-08-5


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Ciprofloxacin HCl, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept